Healthcare leaders are rethinking how campaigns move from draft to market. AI promises faster content creation and shorter MLR cycles, but executives face new questions: How do we balance speed with regulatory scrutiny? How do we preserve the authentic voice of science and patient trust? This panel brings together industry leaders to share perspectives on what’s working, where the pitfalls lie, and how to build responsible, future-ready processes.

• Exploring practical use cases where AI drafting and pre-checks deliver measurable time savings
• Using AI to support – not replace – MLR teams, streamlining collaboration across functions
• Establishing guardrails to protect scientific accuracy and preserve brand credibility
• Partnering with regulators to align expectations and co-create best practices

As pharma companies forge ahead, the need for agility and adaptability in change management becomes crucial for sustained growth. This discussion will explore the new structures and strategies necessary to thrive in

• Transforming marketing frameworks within the pharmaceutical industry, focusing on the shift from traditional linear processes to more collaborative, cross-stakeholder models
• Embracing agile structures and strategies that allow for quick adaptation to changes in the market and organizational landscape
• Redefining decision-making roles and understanding the new leadership structure and how decisions will be made